Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types

Area of Science:

• Molecular Biology
• Virology
• Oncology

Background:

• Human papillomavirus (HPV) infection is a major cause of cervical cancer.
• Accurate detection and typing of HPV are crucial for diagnosis and management.
• Existing HPV detection methods may have limitations in sensitivity or scope.

Purpose of the Study:

• To develop and validate a novel uniplex E6/E7 polymerase chain reaction (PCR) assay for detecting multiple HPV types.
• To evaluate the assay's performance against a commercial HPV genotyping method.
• To assess the utility of the assay in clinical samples, including high-grade squamous intraepithelial lesions (HSIL) and squamous cell carcinoma (SCC).

Main Methods:

• Development of a uniplex E6/E7 PCR assay targeting E6 and E7 genes of 39 HPV types.
• Validation of sensitivity and specificity using cloned HPV DNA and clinical cervical cell samples.
• Comparative analysis with the Genosearch-31 (GS-31) HPV genotyping assay.

Main Results:

• The uniplex E6/E7 PCR assay detected E6/E7 genes from 15 low-risk, 11 intermediate-risk, and 13 high-risk HPV types.
• The assay demonstrated a detection limit of 100 copies for all 39 HPV types with no cross-reactivity.
• HPV was detected in 100% (226/226) of cervical samples, compared to 99.6% by GS-31, with specific findings in HSIL and SCC cases regarding single vs. multiple HPV infections.

Conclusions:

• The developed uniplex E6/E7 PCR assay exhibits high sensitivity and specificity for detecting a broad range of HPV types.
• This assay is a potentially valuable tool for epidemiological surveillance of HPV infections.
• The assay can aid in clinical follow-up after surgical interventions for HPV-related lesions.